Enter assignee name

% Expired Patents = 100.0

Forward Citations = 61

Loading Chart...

7 inventors (with patents filed for the assignee):

Matthew Oliver Fraser (7 out of 9 patents)

Steven B Landau (5 out of 10 patents)

Edward C Burgard (5 out of 5 patents)

4. Karl Bruce Thor (4 out of 16 patents)

5. Cheryl L Miller (3 out of 3 patents)

6. Robert William Gristwood (1 out of 21 patents)

7. David J Cavalla (1 out of 44 patents)

9 patents: Sort by Forward Citations

1. 7470690 - 4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidine in the treatment of functional bowel disorder (2008-12-30),

2. 7459430 - Methods of using ziconotide to treat overactive bladder (2008-12-02),

3. 7223754 - Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders (2007-05-29),

4. 7125848 - Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators (2006-10-24),

5. 7115606 - Method of treating lower urinary tract disorders (2006-10-03),

6. 7094786 - Method of treating nausea, vomiting, retching or any combination thereof (2006-08-22),

7. 7084116 - [object Object] (2006-08-01),

8. 7041704 - Methods of treating gastrointestinal tract disorders using sodium channel modulators (2006-05-09),

9. 6846823 - Method of treating lower urinary tract disorders (2005-01-25),

Dynogen Pharmaceuticals, Inc. is a leading biopharmaceutical company focused on developing innovative therapies for gastrointestinal disorders. With a strong commitment to research and development, Dynogen is dedicated to improving the lives of patients suffering from conditions such as irritable bowel syndrome and inflammatory bowel disease. Through cutting-edge science and a patient-centered approach, Dynogen is driving advancements in the field of gastroenterology.

This text is generated by artificial intelligence and may not be accurate.